This opportunity is no longer accepting applications.
grant NOT-MH-25-050

Notice of Special Interest (NOSI): AI/ML in Pre-Clinical Drug Development for Psychiatric Disorders

This grant opportunity focuses on preclinical drug discovery and does not cover IND-enabling studies, manufacturing scale-up, or clinical research and development. It encourages collaborative team efforts involving experts from computational sciences, biology, and psychiatric diseases. The use of AI and its subsets, including machine learning, deep learning, neural networks, and natural langua…

The focus of this NOSI is on preclinical drug discovery. Investigational New Drug (IND)-enabling studies, scale-up for manufacturing, and clinical research and development are out of the scope of this NOSI. Team science approaches where the strength and knowledge of multiple individuals across c…

Funding Source

Agency: National Institutes of Health
Sub-agency: National Institute of Mental Health

Dates

Opportunity Released: December 20, 2024

Supporting links

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Already have an account? Sign In

Trusted by 500+ Happy Customers

Get opportunities sent to your inbox

The latest grant news and insights from our experts.

Save this opportunity and explore more

Share Opportunity

Share this opportunity with others.
Anyone with this link can view the opportunity details.